These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 6229263)
1. The effects of ICI 118,587 and atenolol on the responses to exercise and on breathlessness in healthy subjects. O'Neill PA; Morton PB; Sharman P; Marlow HF; Stark RD Br J Clin Pharmacol; 1984 Jan; 17(1):37-41. PubMed ID: 6229263 [TBL] [Abstract][Full Text] [Related]
2. Submaximal, but not maximal, exercise testing detects differences in the effects of beta-blockers during treadmill exercise: a study of celiprolol and atenolol. II. McLenachan JM; Grant S; Ford I; Henderson E; Dargie HJ Am Heart J; 1991 Feb; 121(2 Pt 2):691-6. PubMed ID: 1671188 [TBL] [Abstract][Full Text] [Related]
3. Acute response to submaximal and maximal exercise consequent to beta-adrenergic blockade: implications for the prescription of exercise. Wilmore JH; Freund BJ; Joyner MJ; Hetrick GA; Hartzell AA; Strother RT; Ewy GA; Faris WE Am J Cardiol; 1985 Apr; 55(10):135D-141D. PubMed ID: 3993545 [TBL] [Abstract][Full Text] [Related]
4. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of xamoterol, atenolol and propranolol on breathlessness, fatigue and plasma electrolytes during exercise in healthy volunteers. Sørensen EV; Jensen HK; Faergeman O Eur J Clin Pharmacol; 1991; 41(1):51-5. PubMed ID: 1685993 [TBL] [Abstract][Full Text] [Related]
6. An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man. Marlin GE; Kumana CR; Kaye CM; Smith DM; Turner P Br J Clin Pharmacol; 1975 Apr; 2(2):151-7. PubMed ID: 1234497 [TBL] [Abstract][Full Text] [Related]
7. Cardiorespiratory alterations consequent to endurance exercise training during chronic beta-adrenergic blockade with atenolol and propranolol. Wilmore JH; Ewy GA; Freund BJ; Hartzell AA; Jilka SM; Joyner MJ; Todd CA; Kinzer SM; Pepin EB Am J Cardiol; 1985 Apr; 55(10):142D-148D. PubMed ID: 3993546 [TBL] [Abstract][Full Text] [Related]
8. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension. Lund-Johansen P Br J Clin Pharmacol; 1976 Jun; 3(3):445-51. PubMed ID: 973971 [TBL] [Abstract][Full Text] [Related]
9. Ventilatory effects of atenolol and bevantolol in asthma. Lammers JW; Folgering HT; van Herwaarden CL Clin Pharmacol Ther; 1985 Oct; 38(4):428-33. PubMed ID: 4042527 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of ICI 118,587, a new beta-adrenoceptor partial agonist in man. Sasayama S; Yokawa S; Akiyama M; Mikawa M; Sakai O Jpn Circ J; 1986 Jul; 50(7):636-43. PubMed ID: 2877103 [TBL] [Abstract][Full Text] [Related]
11. Effect of beta1 selective adrenoceptor blockade on physiological response to exercise. Gordon NF; van Rensburg JP; Russell HM; Kawalsky DL; Celliers CP; Cilliers JF; Myburgh DP Br Heart J; 1985 Jul; 54(1):96-9. PubMed ID: 3925972 [TBL] [Abstract][Full Text] [Related]
12. A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients. Lammers JW; Müller ME; Folgering HT; van Herwaarden CL Br J Clin Pharmacol; 1986 Nov; 22(5):595-602. PubMed ID: 2878680 [TBL] [Abstract][Full Text] [Related]
13. The effects of antihypertensive medications on the physiological response to maximal exercise testing. Derman WE; Sims R; Noakes TD J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S122-7. PubMed ID: 1381788 [TBL] [Abstract][Full Text] [Related]
14. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men. Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847 [TBL] [Abstract][Full Text] [Related]
15. Exercise training during long-term beta-blockade treatment in healthy subjects. Savin WM; Gordon EP; Kaplan SM; Hewitt BF; Harrison DC; Haskell WL Am J Cardiol; 1985 Apr; 55(10):101D-109D. PubMed ID: 3993543 [TBL] [Abstract][Full Text] [Related]
16. Differentiation of exercise-induced metabolic responses during selective beta 1- and beta 2-antagonism. Hespel P; Lijnen P; Vanhees L; Fagard R; Fiocchi R; Moerman E; Amery A Med Sci Sports Exerc; 1986 Apr; 18(2):186-91. PubMed ID: 3010028 [TBL] [Abstract][Full Text] [Related]
17. Adding beta-2 agonism does not improve beta-1 blockade exercise responses in hypertensives. Rueckert PA; Slane PR; Hanson P Med Sci Sports Exerc; 1994 Aug; 26(8):945-50. PubMed ID: 7968427 [TBL] [Abstract][Full Text] [Related]
18. Assessment of the relative safety of the beta-blockers ICI 141,292 and atenolol in patients with bronchial asthma. Groth S; Tønnesen P; Asted M; Dirksen H; Sørensen PG Eur J Clin Pharmacol; 1986; 30(6):653-8. PubMed ID: 3533563 [TBL] [Abstract][Full Text] [Related]
19. Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion. van Baak MA; Verstappen FT; Oosterhuis B Eur J Clin Pharmacol; 1986; 30(4):399-406. PubMed ID: 3743615 [TBL] [Abstract][Full Text] [Related]
20. Comparison of antihypertensive activity of atenolol and methyldopa at rest and during exercise. Magnani B; Ambrosioni E; Costa FV; Malini PL; Magelli C Int J Clin Pharmacol Ther Toxicol; 1981 Oct; 19(10):440-4. PubMed ID: 7287240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]